Showing 52,061 - 52,080 results of 226,405 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((largest decrease) OR (larger decrease)) ))', query time: 1.66s Refine Results
  1. 52061
  2. 52062

    Vanadium(V<sup>IV</sup>)–Porphyrin-Based Metal–Organic Frameworks for Synergistic Bimetallic Activation of Inert C(sp<sup>3</sup>)–H Bonds by Yefei Wang (430888)

    Published 2022
    “…Taking advantage of the high stability of Zr<sub>6</sub> clusters, the new Zr–MOF was recyclable six times without a conversion efficiency decrease. From this foundation, {Mn<sub>3</sub>(μ<sub>3</sub>-O)} cluster nodes with potential unsaturated coordinated sites were introduced into MOFs to replace Zr<sub>6</sub> clusters, realizing the pre-activation of substrates through the interaction between Mn nodes and substrates. …”
  3. 52063

    Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation by Stephanie K. Guest (2838575)

    Published 2016
    “…Treatment with dasatinib caused a decrease in src-phosphorylation and inhibition of downstream pathways, including AKT and ERK1/2 in all cell lines tested, but only the MCF7-TAMR showed a concomitant decrease in markers of cell cycle progression. …”
  4. 52064

    VEGF and sFlt-1 mutants exhibit changes in stem cell marker gene expression by RT-qPCR. by Christopher R. Schlieve (3179439)

    Published 2016
    “…(B) Bmi1 expression decreased 0.42 fold (*p = 0.03) and Wdr43 expression decreased 0.60 fold (*p = 0.004) in sFlt-1 mutants compared to littermates. sFlt-1 mutants demonstrated a 2.47-fold increase in expression of EphB2 (*p = 0.02) and a 1.50-fold increase in Sox9 expression (*p = 0.004); N = 6 mice per group; Error bars = STDEV.…”
  5. 52065
  6. 52066
  7. 52067
  8. 52068

    Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

    Published 2023
    “…A more potent SERT inhibitor <b>DH4</b> was discovered with a bioavailability of 83.28% in rats by replacing the nonbioavailable substructure of approved drug vilazodone. …”
  9. 52069

    Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

    Published 2023
    “…A more potent SERT inhibitor <b>DH4</b> was discovered with a bioavailability of 83.28% in rats by replacing the nonbioavailable substructure of approved drug vilazodone. …”
  10. 52070

    Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

    Published 2023
    “…A more potent SERT inhibitor <b>DH4</b> was discovered with a bioavailability of 83.28% in rats by replacing the nonbioavailable substructure of approved drug vilazodone. …”
  11. 52071

    Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

    Published 2023
    “…A more potent SERT inhibitor <b>DH4</b> was discovered with a bioavailability of 83.28% in rats by replacing the nonbioavailable substructure of approved drug vilazodone. …”
  12. 52072

    Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

    Published 2023
    “…A more potent SERT inhibitor <b>DH4</b> was discovered with a bioavailability of 83.28% in rats by replacing the nonbioavailable substructure of approved drug vilazodone. …”
  13. 52073
  14. 52074
  15. 52075
  16. 52076
  17. 52077
  18. 52078
  19. 52079
  20. 52080